Literature DB >> 23357594

Chronic oroantral fistula: combined endoscopic and intraoral approach under local anesthesia.

Stefano Fusetti1, Enzo Emanuelli, Cristina Ghirotto, Giordana Bettini, Giuseppe Ferronato.   

Abstract

OBJECTIVE: To evaluate the outcome of combined surgical treatment of oroantral communications associated with chronic maxillary sinusitis. PATIENTS AND METHODS: 8 consecutive patients affected by complicated oroantral fistula were included in the study. The protocol consisted of: clinical, endoscopic and radiological preoperative evaluation (panoramic tomogram and computed tomography); systemic antibiotic and steroid therapy 2 weeks before surgery; one-stage surgical procedure under local anaesthesia consisting in uncinectomy with enlargement of the osteomeatal complex through endoscopic nasal approach associated with the closure of the oroantral communication by means of a mucoperiosteal flap; postoperative antibiotic and cortisone-based therapy. Follow-up consisted of weekly clinical evaluation during the first month, and nasal endoscopy at 3, 8 and 24 weeks after surgery.
RESULTS: After surgical treatment, all patients were symptom-free and had no endoscopic and radiological evidences of maxillary sinusitis at the 6-month follow-up. No recurrent oroantral fistulas were found.
CONCLUSIONS: The current prospective study showed that a one-stage, combined endoscopic and intraoral approach under local anaesthesia represents a feasible and minimally invasive procedure for the long-term effective treatment of chronic complicated oroantral communications. Moreover, it represents an easily applicable approach also in outpatient clinics with minor patient discomfort.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23357594     DOI: 10.1016/j.amjoto.2012.12.015

Source DB:  PubMed          Journal:  Am J Otolaryngol        ISSN: 0196-0709            Impact factor:   1.808


  7 in total

1.  One stage combined endoscopic and per-oral buccal fat pad approach for large oro-antral-fistula closure with secondary chronic maxillary sinusitis.

Authors:  Gilad Horowitz; Ilan Koren; Narin Nard Carmel; Sagi Balaban; Sara Abu-Ghanem; Dan M Fliss; Shlomi Kleinman; Vadim Reiser
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-05-26       Impact factor: 2.503

2.  Odontogenic sinusitis involving the frontal sinus: is middle meatal antrostomy enough?

Authors:  Omer J Ungar; Daniel Yafit; Shlomi Kleinman; Vadim Raiser; Ahmad Safadi
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-07-27       Impact factor: 2.503

3.  Combined endoscopic and intra-oral approach for chronic maxillary sinusitis of dental origin-a prospective clinical study.

Authors:  Prajwalit Kende; Paul C Mathai; Jayant Landge; Neha Aggarwal; Monali Ghodke; Natarajan Chellappa; Vikas Meshram
Journal:  Oral Maxillofac Surg       Date:  2019-07-22

4.  Frequency of the odontogenic maxillary sinusitis extended to the anterior ethmoid sinus and response to surgical treatment.

Authors:  Rafael Crovetto-Martínez; Francisco-Javier Martin-Arregui; Aitor Zabala-López-de-Maturana; Kiara Tudela-Cabello; Miguel-Angel Crovetto-de la Torre
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2014-07-01

5.  Monolateral sinonasal complications of dental disease or treatment: when does endoscopic endonasal surgery require an intraoral approach?

Authors:  G L Fadda; M Berrone; E Crosetti; G Succo
Journal:  Acta Otorhinolaryngol Ital       Date:  2016-08       Impact factor: 2.124

Review 6.  Definition and management of odontogenic maxillary sinusitis.

Authors:  Soung Min Kim
Journal:  Maxillofac Plast Reconstr Surg       Date:  2019-03-29

7.  Chronic maxillary sinusitis of dental origin and oroantral fistula: The results of combined surgical approach in an Italian university hospital.

Authors:  Massimo Galli; Giulia De Soccio; Fabrizio Cialente; Francesca Candelori; Francesca Romana Federici; Massimo Ralli; Marco De Vincentiis; Antonio Minni
Journal:  Bosn J Basic Med Sci       Date:  2020-11-02       Impact factor: 3.363

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.